Active ingredient
Hydromorphone
74 finished FDA listings contain Hydromorphone as their only active ingredient.
FDA NDC Directory
- Ingredient names as written by FDA
- HYDROMORPHONE HYDROCHLORIDE
- Dosage forms
- Injection, Injection, Solution, Solution, Suppository, Tablet, Tablet, Extended Release
- Routes
- Intramuscular, Intravenous, Oral, Rectal, Subcutaneous
- Manufacturers / labelers
- 17
- Strengths listed
- .2 mg/ml · .25 mg/.5ml · .5 mg/.5ml · 1 mg/ml · 10 mg/ml · 12 mg/1 · 16 mg/1 · 2 mg/1 · 2 mg/ml · 3 mg/1 · 32 mg/1 · 4 mg/1 · 4 mg/ml · 5 mg/5ml · 8 mg/1
- Brand names in FDA listings
- Dilaudid
RxNorm (National Library of Medicine)
Ingredient concept RxCUI 3423
Drugs@FDA applications
Linked only where the FDA listing’s application number matches Drugs@FDA exactly. A listing in the NDC Directory does not by itself mean FDA approval.
| Application | Sponsor | Original approval | Listings |
|---|---|---|---|
| NDA 019034 | FRESENIUS KABI USA | 1984-01-11 | 7 |
| NDA 019892 | RHODES PHARMS | 1992-12-07 | 12 |
| NDA 019891 | RHODES PHARMS | 1992-12-07 | 3 |
| ANDA 074653 | HIKMA | 1998-07-29 | 1 |
| ANDA 076855 | SPECGX LLC | 2004-12-23 | 6 |
| ANDA 078591 | HOSPIRA INC | 2008-06-17 | 4 |
| NDA 200403 | HOSPIRA INC | 2011-12-01 | 8 |
| ANDA 204278 | PADAGIS US | 2015-04-06 | 4 |
| ANDA 205814 | AUROLIFE PHARMA LLC | 2016-05-13 | 4 |
| ANDA 205629 | OSMOTICA PHARM US | 2016-07-07 | 4 |
| ANDA 210176 | ASCENT PHARMS INC | 2017-10-27 | 1 |
| ANDA 210506 | ASCENT PHARMS INC | 2018-01-17 | 3 |
| ANDA 202159 | HIKMA | 2018-04-27 | 1 |
| ANDA 212133 | ASCENT PHARMS INC | 2020-09-23 | 8 |
| NDA 217812 | HIKMA | 2023-12-14 | 1 |
| ANDA 216899 | HIKMA | 2024-02-09 | 4 |
Official labeling on DailyMed
- DILAUDID (HYDROMORPHONE HYDROCHLORIDE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] · version 6 · 2026-08-31
- HYDROMORPHONE HYDROCHLORIDE INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] · version 7 · 2026-08-28
- HYDROMORPHONE HYDROCHLORIDE INJECTION [HIKMA PHARMACEUTICALS USA INC.] · version 4 · 2026-08-27
- HYDROMORPHONE HYDROCHLORIDE TABLET [REDPHARM DRUG] · version 1 · 2026-08-26
- HYDROMORPHONE HYDROCHLORIDE INJECTION, SOLUTION [HIKMA PHARMACEUTICALS USA INC.] · version 2 · 2026-08-25
- HYDROMORPHONE HYDROCHLORIDE INJECTION [HIKMA PHARMACEUTICALS USA INC.] · version 9 · 2026-08-11
- HYDROMORPHONE HYDROCHLORIDE TABLET [SPECGX LLC] · version 29 · 2026-07-06
- HYDROMORPHONE HYDROCHLORIDE TABLET [BRYANT RANCH PREPACK] · version 20 · 2026-06-30
- HYDROMORPHONE HYDROCHLORIDE TABLET [ST. MARY'S MEDICAL PARK PHARMACY] · version 1 · 2026-06-11
- HYDROMORPHONE HYDROCHLORIDE TABLET HYDROMORPHONE HYDROCHLORIDE SOLUTION [RHODES PHARMACEUTICALS LLC] · version 20 · 2026-05-20
- DILAUDID (HYDROMORPHONE HYDROCHLORIDE) TABLET DILAUDID (HYDROMORPHONE HYDROCHLORIDE) SOLUTION [RHODES PHARMACEUTICALS LLC] · version 12 · 2026-05-20
- HYDROMORPHONE HYDROCHLORIDE INJECTION, SOLUTION [TEVA PARENTERAL MEDICINES, INC.] · version 15 · 2026-05-20
Showing the 12 most recent of 31 labels.
Sources: FDA NDC Directory (2026-09-29), RxNorm, Drugs@FDA, DailyMed. Each source’s facts are shown separately as published.